On November 13, 2026, the shares of CollPlant Biotechnologies will begin trading on Nasdaq under a new ticker symbol, OPHI. The company’s proposed new name — OptiPhi Computing Ltd. — is a different matter: it goes to a shareholder vote at an extraordinary general meeting on November 24, and it takes effect only if shareholders approve it and the Israeli Registrar of Companies consents. Two changes, two statuses, announced nine days apart — and coverage has already started calling the company OptiPhi. It is not OptiPhi yet.
That distinction is the whole story. A ticker change is an administrative act: the same shares, the same CUSIP number, a different four-letter code on a screen. A name change is a statement of intent that has to survive a vote. Neither is a product milestone, a customer order, or a performance result — the announcements disclose no new LightSolver performance figure, order, or revenue number. But a listed company renaming itself around a laser computer is a different kind of market signal. The defense agreement proved a customer would pay. The Innovation Authority grant proved a government panel would fund. A rebrand proves that a board is willing to stake the company’s public identity on photonic computing. Identity is cheap to announce and expensive to reverse.
What was actually announced
The facts come from three company announcements issued via GlobeNewswire.
On November 4, CollPlant announced that its board had approved a proposal to change the company’s name to OptiPhi Computing Ltd., subject to shareholder approval and regulatory procedures. The proposed name — optics plus physics — reflects the company’s focus on computing with light following its September 2026 acquisition of LightSolver. The proposal goes to shareholders on November 24, 2026; the company also intends to change its Nasdaq symbol from “CLGN” to “OPHI,” subject to Nasdaq confirmation. Until the changes take effect, the company continues to operate as CollPlant Biotechnologies and trade as CLGN.
The formal notice, filed as a Form 6-K on November 3, calls the extraordinary general meeting for Tuesday, November 24, 2026, at 10:00 a.m. Israel time in Tel Aviv, with a record date of November 5. The name change is the meeting’s only item, the board recommends a vote in favor, approval requires a majority of the voting power represented and voting, and the change takes effect only after the Israeli Registrar of Companies consents.
On November 12, CollPlant announced that its shares will begin trading under the new ticker OPHI effective at the open of trading on November 13, 2026, with the shares trading under CLGN through the close of trading on November 12. No shareholder action is required; the CUSIP number is unchanged. The release repeats the caveat: the name change to OptiPhi Computing remains subject to shareholder approval on November 24 and the Registrar’s consent.
Dr. Ruti Ben Shlomi, LightSolver’s co-founder and CEO, put the ambition plainly: “We believe the future of computing will be built on light.” In the November 12 release she added that the LPU has “the potential to solve demanding workloads at significantly higher speeds while reducing energy consumption” — potential, note, not a measured result.
Ten weeks that remade a listing
The rebrand is the third act of a sequence that began the day the acquisition closed, and the sequence is what gives a name change its weight. On September 3, 2026, CollPlant closed its acquisition of LightSolver, an Israeli deep-tech company founded in 2020 by Weizmann Institute physicists Ben Shlomi and Dr. Chene Tradonsky. LightSolver builds the Laser Processing Unit (LPU), a closed-loop, all-optical computer.
On October 29, CollPlant announced the paid, multi-year framework agreement between LightSolver and the Directorate of Defense Research & Development within the Israel Ministry of Defense, following earlier successful proof-of-concept work, with an initial order covering the first 12 months. This desk covered it on October 30: no contract value, no benchmark, no named application — a paid defense program is evidence about a customer’s judgment, not about a machine’s performance.
On November 5, CollPlant announced that the Israel Innovation Authority had approved a grant of approximately $1.8 million to LightSolver for continued development of the LPU, covering new PDE-solving hardware, customer R&D tools for the LPU Lab platform, and HPC integration alongside CPUs and GPUs. This desk covered it on November 9: a government grant validates differently than a customer agreement — and $1.8 million is far less than commercialization will require.
On November 11, LightSolver announced it will give the first public demonstration of the LPU at SC26, the International Conference for High Performance Computing, in Chicago, November 15–20, with demonstrations at booth #5102, November 16–19. It will also present Boeing corrosion-simulation work at the Exhibitor Forum, with comparative benchmark results against existing solvers promised.
Read in order, the five announcements describe a company assembling the scaffolding of a serious hardware business: a paid defense customer, a government grant, a public demonstration with promised benchmarks, a new ticker, and a proposed new name. None of those is a benchmark, but coherence across independent institutions is itself a signal, weaker than a measurement, stronger than a single press release. The rebrand ties the others together into a single public identity — and is the hardest piece to undo.
Why a name is a different kind of signal
There is a reason to take a corporate renaming seriously even when it contains no technical news: names are commitment devices. A press release can be forgotten; a listing name cannot. Once a company trades as OptiPhi Computing, every filing and announcement carries the photonic identity in its header. If the LPU fails to commercialize, the company cannot quietly return to being a biotech stock — the name will keep advertising a bet that did not pay off.
The rebrand also solves a problem this desk flagged in October: a laser computer inside a regenerative medicine company’s listing. CollPlant was known for plant-derived recombinant human collagen for regenerative medicine. A name that describes the business you are actually in is a practical asset with customers, recruits, and partners, and “OptiPhi” does that work in a single word.
There is a second, quieter function: a name change is the cheapest way for a public company to signal where it intends to allocate capital — and readers should check that signal against actual spending in future filings.
The biotech half hasn’t gone away
The honest caveat is that the company being renamed still owns the business it is renaming itself away from. CollPlant still describes itself as operating “at the intersection of deep-tech photonic computing and advanced biotechnology,” and says it “retains” its plant-derived recombinant human collagen (rhCollagen) and bio-ink assets for 3D bioprinting and medical aesthetics. The collagen business has not been sold, spun out, or wound down in any announcement to date — so OptiPhi Computing would be a photonic computing company that still owns a biotech business.
That limits how clean the identity story is. The rebrand is a statement about direction, not a description of the present: the name “reflects” an expanded focus and an “ambition,” in Ben Shlomi’s word. A name that describes where a company is going is useful; a name mistaken for a description of where it already is would be misleading. The same discipline applies to the ticker: OPHI begins trading today, but a ticker is not a valuation, a rating, or an endorsement. It changes how the shares are looked up, not what they are worth; nothing in either announcement discloses a share price. This desk does not make investment recommendations, and a renaming is not a reason to start.
The scrutiny file
A careful reader should carry the same list of what remains unproven that this desk has carried since October 30, because the rebrand narrows none of it.
First, no performance evidence is offered. Neither release contains a benchmark, a problem size, a time-to-solution, or an energy figure for the LPU. Ben Shlomi’s “potential” phrasing is explicitly forward-looking, and the releases warn the LPU’s anticipated performance, capabilities, and energy efficiency may not materialize. Trade coverage has cited projected accelerations derived from emulation, not from a delivered system — modeling results awaiting hardware confirmation.
Second, no new commercial evidence is disclosed. There is no new customer, no new order, and no revenue figure in either announcement. The releases restate the existing institutional base — Boeing, the Defense Ministry, European Innovation Council funding, HLRS research — but add no new name to it.
Third, the name change itself is not certain. It requires a shareholder vote on November 24 and the consent of the Israeli Registrar of Companies, and the releases warn that approval or consent may not be obtained, or that the name approved may differ from the proposed name. The board recommends a vote in favor, which makes approval the expected outcome — but expected is not certain.
Fourth, the commercial timeline is unchanged: trade coverage describes proof-of-concept and minimum-viable-product systems for 2027 and a standard system for 2028 — company-set milestones, which slip more often than they hold. Fifth, the grant’s strings still apply: the IIA funding carries royalty obligations and restrictions on transferring IIA-funded know-how and manufacturing outside Israel — standard terms, but real constraints on manufacturing at scale.
Where this fits
The OptiPhi rebrand is the corporate-form counterpart to a shift this desk has tracked since the defense agreement: the field’s center of gravity is moving from laboratory demonstrations toward institutions that have to answer for results. Most photonic computing companies are still private venture-backed startups, and their identity is whatever their founders say it is. A listed company answers to filings, a shareholder vote, and a ticker that changes on a stated date — which makes its identity claims more consequential and more checkable. When a public company renames itself around a technology, the claim is on the record in a way a startup’s pitch deck is not.
The rebrand also marks a dividing line inside the field itself. The dominant commercial story has been AI inference: optical accelerators for datacenter AI workloads, competing on energy per operation against GPUs. LightSolver’s LPU is aimed at a different class of problem — high-dimensional mathematical workloads, optimization, and the large systems of partial differential equations that underpin physics-based simulation — and its early customers are engineering, defense, and government institutions, not datacenter AI operators. Renaming itself around that bet is the most public way of saying the simulation-and-optimization market is large enough to carry a listed company.
What to watch
Five developments would turn this rebrand from an identity statement into a capability story.
First, the November 24 vote: whether the name change is approved, whether the Registrar consents, and whether the approved name is the proposed name. A completed rebrand confirms the company’s public identity is now the laser computer; a rejection would say something equally informative about how shareholders view the bet.
Second, the SC26 demonstration, November 16–19 in Chicago: whether the LPU runs live, and — most importantly — the comparative benchmarks promised for the Boeing corrosion-simulation presentation. Stated results against a digital baseline would be the first public performance evidence for the LPU.
Third, a named problem class with stated results on LPU hardware, against a digital baseline, outside the controlled setting of a conference demonstration. Fourth, a peer-reviewed publication on the LPU’s architecture and behavior on a real problem, beyond the HLRS sparse-solver work — ideally one reporting measured, not emulated, performance. Fifth, movement on the funded programs: IIA grant disbursement, a funded second phase of the defense framework, and a customer using the LPU Lab tools for independent R&D.
Until those appear, the fair summary is this: CollPlant’s shares begin trading as OPHI today, and its proposed name change to OptiPhi Computing goes to shareholders on November 24. The ticker is done; the name awaits a vote and a regulator’s consent. Neither discloses a new benchmark, customer, or revenue figure. What they disclose is a board willing to stake the company’s public identity on computing with light — a signal worth taking seriously, and a claim worth testing at SC26 next week.
Sources and further reading
The core facts — the board-approved proposal to rename the company OptiPhi Computing Ltd., the November 24, 2026 shareholder meeting, the proposed ticker change from CLGN to OPHI, the September 2026 LightSolver acquisition, and the quoted remarks from Dr. Ruti Ben Shlomi — come from CollPlant Biotechnologies’ announcement via GlobeNewswire on November 4, 2026. The ticker change effective at the open of trading on November 13, 2026, the unchanged CUSIP, and the confirmation that the name change remains subject to shareholder approval and the Registrar’s consent come from CollPlant’s announcement of November 12, 2026. The meeting details come from the notice of extraordinary general meeting filed as a Form 6-K on November 3, 2026. The Ministry of Defense framework agreement, the Israel Innovation Authority grant of approximately $1.8 million, the Boeing engineering program, and the HLRS research are as covered by this desk on October 30 and November 9, 2026. The SC26 first public demonstration and the Boeing corrosion-simulation presentation come from LightSolver’s announcement of November 11, 2026. The 2027–2028 timeline and the emulator-derived speedup projections are as described in trade coverage, not as company-disclosed measurements; no LPU benchmark on delivered hardware was available at the time of writing.